The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma

Overview of attention for article published in BMC Cancer, May 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 238 followers.

◈ The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant ... http://t.co/0oIfSbjRuI ◈

The combination of sorafenib and everolimus shows antitumor activity in preclinical models http://t.co/b9ju8FWFz7

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.